Perfusion System Market (By Technology: Hypothermic, Normothermic; By Organ Type: Heart, Lung, Kidney, Liver, Others; By Application: Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-vivo Organ Perfusion System) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20222030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Perfusion System Market 

5.1. COVID-19 Landscape: Perfusion System Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Perfusion System Market, By Technology

8.1. Perfusion System Market, by Technology, 2022-2030

8.1.1 Hypothermic

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Normothermic

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Perfusion System Market, By Organ Type

9.1. Perfusion System Market, by Organ Type, 2022-2030

9.1.1. Heart

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Lung

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Kidney

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Liver

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Perfusion System Market, By Application 

10.1. Perfusion System Market, by Application, 2022-2030

10.1.1. Cardiopulmonary Perfusion System

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Cell Perfusion System

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Ex-vivo Organ Perfusion System

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Perfusion System Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Technology (2017-2030)

11.1.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.1.3. Market Revenue and Forecast, by Application (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Technology (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.1.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Technology (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.1.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Technology (2017-2030)

11.2.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.2.3. Market Revenue and Forecast, by Application (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Technology (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.2.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Technology (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.2.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Technology (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.2.6.3. Market Revenue and Forecast, by Application (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Technology (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.2.7.3. Market Revenue and Forecast, by Application (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Technology (2017-2030)

11.3.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.3.3. Market Revenue and Forecast, by Application (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Technology (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.3.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Technology (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.3.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Technology (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.3.6.3. Market Revenue and Forecast, by Application (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Technology (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.3.7.3. Market Revenue and Forecast, by Application (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Technology (2017-2030)

11.4.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Technology (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.4.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Technology (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.4.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Technology (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.4.6.3. Market Revenue and Forecast, by Application (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Technology (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.4.7.3. Market Revenue and Forecast, by Application (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Technology (2017-2030)

11.5.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Technology (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.5.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Technology (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Organ Type (2017-2030)

11.5.5.3. Market Revenue and Forecast, by Application (2017-2030)

Chapter 12. Company Profiles

12.1. Getinge AB

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Medtronic, plc

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. LivaNova

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Terumo Corporation

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Nipro Corporation

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. XENIOS AG

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Repligen Corporation

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Spectrum Laboratories, Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Merck KGaA

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Harvard Bioscience, Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms